TITLE:
Naltrexone in Treatment of Cocaine Dependence - 5

CONDITION:
Cocaine-Related Disorders

INTERVENTION:
Naltrexone

SUMMARY:

      The purpose of this study is to determine the efficacy of naltrexone in the treatment of
      cocaine dependence as measured by: 1) decreased urine benzoylecgonine (BE) levels, 2)
      decreased cocaine use by self-report, 3) decreased cocaine craving, and 4) retention in
      treatment.
    

DETAILED DESCRIPTION:

      Double-blind, placebo controlled study of the safety and efficacy of naltrexone in treating
      cocaine dependence in a patient sample that initiated the study while in an inpatient
      setting and were then followed-up for 3 months as outpatients.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion Criteria:

          1. Meet DSM-III-R criteria for cocaine dependency,

          2. 18 to 65 years of age,

          3. capable of understanding the study,

          4. voluntarily signed consent,

          5. male or non-pregnant female using approved form of birth control.

        Exclusion Criteria:

          1. abnormal liver function tests (SGOT, SGPT, or GGT greater than twice the normal
             values),

          2. opioid use within the last 7 days,

          3. use of neuroleptics,

          4. having a severe acute medical problem,

          5. unable to complete psychiatric rating scales, or

          6. judged by the investigator to be unlikely to comply with the study protocol
      
